14 Paid Clinical Research Studies in Overland Park, Kansas

Pharmacokinetics of Zelquistinel in Fasted or Fed State

The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of Zelquistinel 3 mg or 10 mg oral tablets tablets in health

📍 Dr. Vince Clinical Research — Overland Park, Kansas

💵 On Day 1 of each period, participants will receive one of the following treatments: * Treatment A (reference): zelquist

Study of Midomafetamine in Healthy Adults

This Phase 1 study is designed to evaluate the safety and tolerability of midomafetamine in healthy adult participants. The study will also assess how the drug is processed in the

📍 Dr. Vince Clinical Research — Overland Park, Kansas

💵 Participants will receive study drug in a split dose administration (an initial dose followed by an additional dose 1.5

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

The purpose of this study is to generate hypotheses regarding the safety, efficacy, and immunological impact of cladribine tablets after treatment with natalizumab in patients with

📍 College Park Family Care Center Physicians Group — Overland Park, Kansas

💵 All study participants will receive treatment with cladribine 10 mg tablets during year 1 and year 2 according to the ap

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluat

📍 DelRicht Research — Overland Park, Kansas

💵 In the LTFU study, subjects will receive open-label YCANTH (VP-102/TO-208) every 21 days until all treatable common wart

Phase 1 Study of Oral MG001

This research study is the first time the new medication MG001 is being tested in people. MG001 is a formulation of mitragynine, a compound that comes from a plant called Mitragyna

📍 Altasciences Clinical Kansas — Overland Park, Kansas

💵 Participants will receive the assigned treatment on Day 1 after participants have fasted for at least 10 hours.

VK4-116 Phase I Study With Food-Effect

This first-in-human, randomized, double-blind, placebo-controlled, single ascending dose (SAD), phase I study is designed to assess the safety, tolerability and pharmacokinetics of

📍 Altasciences Clinical Kansas — Overland Park, Kansas

Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants

The goal of this clinical trial is to test the safety and to see if there are any side effects of the investigational drug, MCAM. The main aim is to measure blood levels of the stu

📍 Dr. Vince Clinical Research — Overland Park, Kansas

Abuse Liability for Five Modern Oral Nicotine Products

This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological meas

📍 Dr. Vince Clinical Research — Overland Park, Kansas

Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience

The purpose of the present study is to assess prospectively the abuse potential of gabapentin compared to placebo and alprazolam in healthy non-drug-dependent recreational sedative

📍 Dr. Vince Clinical Research — Overland Park, Kansas

💵 On Day 1 of each of the Treatment Phase 4 periods, which will be separated by a washout of at least 6 days, participants

A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

This study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the safety of drug ATI-1

📍 Dr. Vince Clinical Research — Overland Park, Kansas

💵 Each participant will receive one intravenous (IV) infusion of ATI-1013 or placebo (Day 1).

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

The main purposes of this research study are to measure the safety (whether it causes any side effects), tolerability (if it does cause any side effects, how well your body is able

📍 Invivyd Investigative Site — Overland Park, Kansas

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

The purpose of this clinical study is to find out if NNC0662-0419 is safe and effective to be taken together with other medicines, like birth control pills, and emptying of the sto

📍 Altasciences Clinical Kansas, Inc. — Overland Park, Kansas

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD)

📍 Altasciences Inc - Kansas City — Overland Park, Kansas

💵 In each cohort, participants will receive under fasting conditions 11 oral doses of VNT-101 or placebo twice daily (BID)

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single dose of VX-581 and multiple ascending doses of VX-581 alone and in combination wit

📍 Altasciences - Kansas City — Overland Park, Kansas